Get started
Author

Tom Greene

Factors associated with the prevalence of arteriovenous fistulas in hemodialysis patients in the HEMO Study
2000 · Michael Allon, Daniel B. Ornt, et al. · Kidney International · 199
Effects of Canagliflozin in Patients with Baseline eGFR <30 ml/min per 1.73 m2
2020 · George Bakris, Megumi Oshima, et al. · Clinical Journal of the American Society of Nephrology · 141
PDF
Serum Bicarbonate and Long-term Outcomes in CKD
2010 · Vandana Menon, Hocine Tighiouart, et al. · American Journal of Kidney Diseases · 135
Asymmetric Dimethylarginine and Mortality in Stages 3 to 4 Chronic Kidney Disease
2009 · Jill Melendez Young, Norma Terrin, et al. · Clinical Journal of the American Society of Nephrology · 96
Serum alkaline phosphatase levels associate with elevated serum C-reactive protein in chronic kidney disease
2010 · Sriharsha Damera, Kalani L. Raphael, et al. · Kidney International · 75
Kidney, Cardiovascular, and Safety Outcomes of Canagliflozin according to Baseline Albuminuria
2021 · Meg Jardine, Zien Zhou, et al. · Clinical Journal of the American Society of Nephrology · 54
PDF
Rate of ESRD Exceeds Mortality among African Americans with Hypertensive Nephrosclerosis
2010 · Tahira P. Alves, Xuelei Wang, et al. · Journal of the American Society of Nephrology · 52
Kidney and Cardiovascular Effects of Canagliflozin According to Age and Sex: A Post Hoc Analysis of the CREDENCE Randomized Clinical Trial
2023 · Tae Won Yi, Brendan Smyth, et al. · American Journal of Kidney Diseases · 35
PDF
Serum alkaline phosphatase and mortality in hemodialysis patients
2010 · S. Beddhu, B. Baird, et al. · Clinical Nephrology · 33
A meta-analysis of albuminuria as a surrogate endpoint for kidney failure
2025 · Hiddo J. L. Heerspink, Willem H. Collier, et al. · Nature Medicine · 31
Effects of newer kidney protective agents on kidney endpoints provide implications for future clinical trials
2023 · Hiddo J.L. Heerspink, Niels Jongs, et al. · Kidney International · 21
PDF
Cardiovascular Effects of Canagliflozin in Relation to Renal Function and Albuminuria
2022 · Ashish Sarraju, George Bakris, et al. · Journal of the American College of Cardiology · 16
PDF
Rationale, design, demographics and baseline characteristics of the randomized, controlled, Phase 2b SAPPHIRE study of verinurad plus allopurinol in patients with chronic kidney disease and hyperuricaemia
2021 · Hiddo J L Heerspink, Austin G Stack, et al. · Nephrology Dialysis Transplantation · 13
PDF
Glycemic Control and Effects of Canagliflozin in Reducing Albuminuria and eGFR
2023 · Sjoukje van der Hoek, Niels Jongs, et al. · Clinical Journal of the American Society of Nephrology · 11
Clinical Implications of Slope of GFR in Clinical Trials of CKD Progression
2025 · Tom Greene, Willem Collier, et al. · Clinical Journal of the American Society of Nephrology · 6
Changing paradigms of studies in kidney diseases
2025 · Adeera Levin, Allison Jaure, et al. · Kidney International · 3
PDF
Multigene Copy Number Alteration Risk Score Biomarker–Based Enrichment Study Designs in Metastatic Castrate-Resistant Prostate Cancer
2024 · Yeonjung Jo, Jonathan J. Chipman, et al. · JCO Precision Oncology · 2
The Sit Less, Interact and Move More (SLIMM-2) Trial: Protocol for a randomized control trial of a sedentary behavior intervention, resistance training and semaglutide on sedentary behavior in persons with chronic kidney disease
2024 · Jesse C. Christensen, Shuchi Anand, et al. · Contemporary Clinical Trials · 2
PDF
The Effect of Dapagliflozin on Rate of Kidney Function Decline in Patients with CKD: A Prespecified Analysis from the DAPA-CKD Trial
2021 · Hiddo J. L Heerspink, Niels Jongs, et al. · Journal of the American Society of Nephrology · 2
Early Change in Albuminuria with Canagliflozin (CANA) Predicts Kidney and Cardiovascular (CV) Outcomes
2020 · Megumi Oshima, Brendon L. Neuen, et al. · Journal of the American Society of Nephrology · 1
Canagliflozin and Risk of Skin and Soft Tissue Infections in People with Diabetes Mellitus and Kidney Disease in the CREDENCE Trial
2020 · Amy Kang, Brendan Smyth, et al. · Journal of the American Society of Nephrology · 1
PDF
Canagliflozin and Risk of Genital Infections and Urinary Tract Infections in People with Diabetes Mellitus and Kidney Disease in the CREDENCE Trial
2020 · Amy Kang, Brendon L. Neuen, et al. · Journal of the American Society of Nephrology · 1
PDF
Acute Declines in eGFR During Treatment with Canagliflozin (CANA) and Its Implications for Clinical Practice: Insights from CREDENCE
2020 · Hiddo J. L Heerspink, Megumi Oshima, et al. · Journal of the American Society of Nephrology · 1
P1013canagliflozin and Risk of Genital Infections and Urinary Tract Infections in People With Diabetes Mellitus and Kidney Disease- a Post-hoc Analysis of the Credence Trial
2020 · Amy Kang, Brendon Neuen, et al. · Nephrology Dialysis Transplantation · 1
PDF
Study variation in estimating Glomerular Filtration Rate (GFR) from serum creatinine, cystatin C, age, and sex
2026 · Nora Fino, Ben Haaland, et al. · PLoS ONE
PDF
Works count: 46
Citation count: 932
H-index: 13
I10-index: 14
Year
Topic
Type